197 related articles for article (PubMed ID: 36257060)
1. Structure-Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens.
Hu Z; Leus IV; Chandar B; Sherborne BS; Avila QP; Rybenkov VV; Zgurskaya HI; Duerfeldt AS
J Med Chem; 2022 Oct; 65(20):14144-14179. PubMed ID: 36257060
[TBL] [Abstract][Full Text] [Related]
2. Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity.
Takrouri K; Cooper HD; Spaulding A; Zucchi P; Koleva B; Cleary DC; Tear W; Beuning PJ; Hirsch EB; Aggen JB
ACS Infect Dis; 2016 Jun; 2(6):405-26. PubMed ID: 27627629
[TBL] [Abstract][Full Text] [Related]
3. An Update on the Structure of Oxazolidinone Analogs and a Comparison with Linezolid in Terms of In Vitro and Intracellular Efficacy against Clinically Relevant Bacterial Species.
Tang Q; Zhao Y; Xu B; Gong P; Wang D
Jpn J Infect Dis; 2017 Nov; 70(6):678-681. PubMed ID: 28890512
[TBL] [Abstract][Full Text] [Related]
4. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.
Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB
Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
6. Installation of an aryl boronic acid function into the external section of N-aryl-oxazolidinones: Synthesis and antimicrobial evaluation.
Cruz CD; Wrigstedt P; Moslova K; Iashin V; Mäkkylä H; Ghemtio L; Heikkinen S; Tammela P; Perea-Buceta JE
Eur J Med Chem; 2021 Feb; 211():113002. PubMed ID: 33223262
[TBL] [Abstract][Full Text] [Related]
7. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
8. Novel oxazolidinone-quinolone hybrid antimicrobials.
Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
[TBL] [Abstract][Full Text] [Related]
9. Oxazolidinone antimicrobials: a patent review (2012-2015).
Phillips OA; Sharaf LH
Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibiotic activity of oxazolidinone-catechol conjugates against Pseudomonas aeruginosa.
Paulen A; Gasser V; Hoegy F; Perraud Q; Pesset B; Schalk IJ; Mislin GL
Org Biomol Chem; 2015 Dec; 13(47):11567-79. PubMed ID: 26509593
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities.
Ampomah-Wireko M; Chen S; Li R; Gao C; Wang M; Qu Y; Kong H; Nininahazwe L; Zhang E
Eur J Med Chem; 2024 Apr; 269():116326. PubMed ID: 38513340
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
16. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F
Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and antibacterial activity of 1,3,4-thiadiazole phenyl oxazolidinone analogues.
Thomasco LM; Gadwood RC; Weaver EA; Ochoada JM; Ford CW; Zurenko GE; Hamel JC; Stapert D; Moerman JK; Schaadt RD; Yagi BH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4193-6. PubMed ID: 14622999
[TBL] [Abstract][Full Text] [Related]
18. The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class.
Sciotti RJ; Pliushchev M; Wiedeman PE; Balli D; Flamm R; Nilius AM; Marsh K; Stolarik D; Jolly R; Ulrich R; Djuric SW
Bioorg Med Chem Lett; 2002 Aug; 12(16):2121-3. PubMed ID: 12127518
[TBL] [Abstract][Full Text] [Related]
19. WCK 4034: A promising oxazolidinone for treating gram positive infections.
Bhawsar S; Pawar S; Deshpande P; Yeole R; Chavan R; Nandanwar M; Bhagwat S; Patel M
Bioorg Med Chem Lett; 2022 Sep; 71():128842. PubMed ID: 35680102
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the structure-activity relationship and druggability of novel oxazolidinone-based compounds as Gram-negative antibacterial agents.
Ding S; Ji JC; Zhang MJ; Yang YS; Wang R; Zhu XL; Wang LH; Zhong Y; Gao L; Lu M; Liu J; Chen Y
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900129. PubMed ID: 31478565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
